Published :
Tables : 25
Figures : 35
Category : Healthcare
No. of Pages : 220
Report Code : HC-1053
Cardiac Diagnostic Testing Devices Market Introduction: The Global Cardiac Diagnostic Testing Devices Market is estimated to value over USD 8.9 billion by 2027 end with a CAGR of over 5.9% during the forecast period 2020 to 2027. This market study is segmented on the basis of product type, end-user, and region. On the basis of product type the market is segmented into Electrocardiogram (ECG), Echodiogram, Transesophageal Echocardiogram (TEE), Cardiac Catheterization. By end-user, the market is segmented into Hospital, Clinics, Diagnostic Laboratories, Long Term Care Centres, Homecare Settings, Ambulatory Surgical Centres, Cath Labs, Emergency Medical Services. Regionally the market is segmented into Europe, North America, Latin America and APAC and rest of the word. Some of the major market players are: Abbott, GE Healthcare, Koninklijke Philips, Bayer AG, bioMerieux Inc., Danaher, F. Hoffmann La Roche, Siemens, Beckman Coulter, Hitachi Medical Systems. Cardiac Diagnostic Testing Devices Market Segmentation: By Product Type Electrocardiogram (ECG) Echodiogram Transesophageal Echocardiogram (TEE) Cardiac Catheterization By End-User Hospital Clinics Diagnostic Laboratories Long Term Care Centres Homecare Settings Ambulatory Surgical Centres Cath Labs Emergency Medical Services By Region North America Latin America Europe Asia-Pacific Rest of the world Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global cardiac diagnostic testing devices market is segmented on the basis of product type, end-user, and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in five key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The Global Cardiac Diagnostic Testing Devices Market is estimated to value over USD 8.9 billion by 2027 end with a CAGR of over 5.9% during the forecast period 2020 to 2027.
This market study is segmented on the basis of product type, end-user, and region. On the basis of product type the market is segmented into Electrocardiogram (ECG), Echodiogram, Transesophageal Echocardiogram (TEE), Cardiac Catheterization.
By end-user, the market is segmented into Hospital, Clinics, Diagnostic Laboratories, Long Term Care Centres, Homecare Settings, Ambulatory Surgical Centres, Cath Labs, Emergency Medical Services.
Regionally the market is segmented into Europe, North America, Latin America and APAC and rest of the word.
Some of the major market players are:
Abbott, GE Healthcare, Koninklijke Philips, Bayer AG, bioMerieux Inc., Danaher, F. Hoffmann La Roche, Siemens, Beckman Coulter, Hitachi Medical Systems.
Cardiac Diagnostic Testing Devices Market Segmentation:
By Product Type
By End-User
By Region
Competitive Landscape:
FutureWise Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Cardiac Diagnostic Testing Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Global Cardiac Diagnostic Testing Devices Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Cardiac Diagnostic Testing Devices Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Cardiac Diagnostic Testing Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Cardiac Diagnostic Testing Devices Market, By Product Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Electrocardiogram (ECG) 7.2. Echodiogram 7.3. Transesophageal Echocardiogram (TEE) 7.4. Cardiac Catheterization 8. Global Cardiac Diagnostic Testing Devices Market, By End-User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Hospital 8.2. Clinics 8.3. Diagnostic Laboratories 8.4. Long Term Care Centres 8.5. Homecare Settings 8.6. Ambulatory Surgical Centres 8.7. Cath Labs 8.8. Emergency Medical Services 9. North America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.2.3. Mexico 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Venezuela 10.2.3. Argentina 10.2.4. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. Abbott 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. GE Healthcare 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Koninklijke Philips 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Bayer AG 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5. Danaher 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. F. Hoffmann La Roche 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Siemens 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Beckman Coulter 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Hitachi Medical Systems 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. bioMerieux Inc. 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 15. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics